NEPG(SZ:000597) Mei Ri Jing Ji Xin Wen·2025-09-03 03:34Group 1 - The core point of the article is the resignation of Ms. Zhou Yana from her position as Chief Financial Officer of Northeast Pharmaceutical due to personal health reasons [1] - For the first half of 2025, Northeast Pharmaceutical's revenue composition is as follows: 52.0% from pharmaceutical manufacturing, 46.18% from pharmaceutical commerce, and 1.82% from other industries [1] - As of the time of reporting, Northeast Pharmaceutical has a market capitalization of 8.2 billion [1] Group 2 - Related news includes the resignation of Jin Ting as Chief Financial Officer of Changjiu Logistics [2] - Anfu Technology has appointed Liu Jianbo as its new Chief Financial Officer [2] - Guangyuyuan has appointed Ren Yan as its Chief Financial Officer [2]